← Eichor
Condition: Curative Resection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Curative Resection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcino
EARLY_Phase 1 · 2 location(s) · Dana-Farber Cancer Institute · NCT06664151Colorectal Metastasis Prevention International Trial 2
Phase 2 · 6 location(s) · Assaf-Harofeh Medical Center · NCT03919461ctDNA-MRD Monitoring After Resection in Gastric Cancer
Phase N/A · 1 location(s) · Peking University · NCT06893133Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection
Phase 2 · 1 location(s) · Qilu Hospital of Shandong University · NCT06454578Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Opt
Phase N/A · 1 location(s) · Klinikum Esslingen · NCT04926584Clinical Outcomes After Non-curative Endoscopic Resection in Early Colorectal Cancer: A Multicenter Study
Phase N/A · 3 location(s) · Nanfang Hospital, Southern Medical University · NCT07542171Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06833632NWRD06 DNA Plasmid for HCC After Curative Resection.
Phase 2 · 6 location(s) · Newish Technology (Beijing) Co., Ltd. · NCT07324304Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer
Phase 2 · 1 location(s) · Fudan University · NCT05975749Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)
Phase 2 · 2 location(s) · Samsung Medical Center · NCT04591002The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.
Phase N/A · 1 location(s) · Fondazione Poliambulanza Istituto Ospedaliero · NCT06068023A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection
Phase 3 · 1 location(s) · Akeso · NCT05489289Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With P
Phase 2 · 13 location(s) · Greg Durm, MD · NCT04317534Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma
Phase 2 · 12 location(s) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT07260175Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage
Phase 2 · 2 location(s) · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRS · NCT02919644Using ctDNA to Determine Therapies for Lung Cancer
Phase 2 · 1 location(s) · University Health Network, Toronto · NCT04966663Anesthesia and Non-small Cell Lung Cancer Recurrence
Phase 4 · 1 location(s) · Samsung Medical Center · NCT06330038PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY
Phase 2 · 1 location(s) · Daping Hospital and the Research Institute of Surgery of the · NCT06354140AI-Based Prediction of Liver Metastasis in Colorectal Cancer (A Retrospective Study)
Phase N/A · 1 location(s) · Tongji Hospital · NCT07399236Early Detection of Treatment Failure in Metastatic Colorectal Cancer Patients
Phase N/A · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05068531Prospective Validation of an AI Model for Predicting Liver Metastasis in Colorectal Cancer
Phase N/A · 1 location(s) · Tongji Hospital · NCT07392567Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection
Phase N/A · 3 location(s) · University Health Network, Toronto · NCT05254782A Study of Surgery and Radiotherapy in People With Breast Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07053085Functional Study of Inhibitory Neurotransmission in the Human Epileptic Brain.
Phase N/A · 1 location(s) · Neuromed IRCCS · NCT05459090Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrenc
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06762782APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patient
Phase 2 · 454 location(s) · National Cancer Institute (NCI) · NCT04858334
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.